Biopharma Technology LLC announces partnership with Arete Biosciences to offer enhanced CDMO services in the USA

Biopharma Technology LLC (BTLLC), the dedicated United States division of Biopharma Group, a leading provider of molecular diagnostics and biopharmaceuticals solutions, is pleased to announce a strategic partnership with Arete Biosciences, a California-based life sciences company. This collaboration establishes a dedicated R&D analysis and small batch manufacturing laboratory in the USA, specifically catering to the needs of American customers.

This new facility will offer a comprehensive suite of Contract Development and Manufacturing Organisation (CDMO) services and solutions, focusing on lyophilised (freeze-dried) products and liquid formulations. BTLLC and Arete Biosciences recognise the growing demand for efficient and reliable CDMO services within the US market. This partnership directly addresses this need by providing American biopharmaceutical and diagnostics companies with access to:

• Thermal Analysis Services: Utilising advanced lyo instruments such as Lyostat FDM, Lyotherm, and MicroPress, the lab can assess the thermal properties of your product, ensuring optimal stability and formulation design and offer in-depth thermal analysis to optimise freeze-drying processes.
• Freeze-Dried Formulation & Cycle Development: Benefit from expert formulation development and cycle optimisation optimal freeze-drying formulations and cycles tailored to your specific product requirements.
• Lyobead Generation: Access innovative lyobead generation services, ideal for controlled drug delivery or sustained release applications.
• Small Batch Manufacturing: Leverage the lab's expertise for small batch production runs, perfect for clinical trial materials, proof-of-concept studies, or initial product launches.
• Process Troubleshooting: Receive comprehensive troubleshooting services conducted by experienced scientists to identify and resolve any challenges encountered during your development process.
• Audits and Reviews: Ensure your processes meet the highest standards with thorough audits and insightful reviews from our team.

"This partnership with Arete Biosciences represents a significant step forward in our commitment to serving our American customers," said David Banks, Head of Technical Services and spokesperson for BTLLC. "By establishing a dedicated R&D and manufacturing presence within the USA, we can provide even faster turnaround times, minimise logistical complexities, and offer a more streamlined CDMO experience."

For a detailed overview of Biopharma Group's comprehensive CDMO services and solutions, get in touch with David to discuss your requirements.